CL Consumer Staples · Global brands · Pet nutrition · Dividend defensive · Thesis updated July 19, 2026

Volume is back, but costs are biting

Colgate is still a global staples company built around daily-use products, especially toothpaste and Hill's pet nutrition.
Q1 2026 showed better volume, led by Asia Pacific and Latin America, which helps answer the growth concern from 2025.
The main new problem is cost pressure, with management calling out an extra $300 million raw materials and logistics hit for 2026.
North America remains the weak spot, and management says the region needs a strategy reset.
The stock looks steady but not cheap enough to ignore the margin and execution questions.

01 Running thesis

Emerging markets help, margins hurt

Colgate-Palmolive has the kind of business investors often like in rough markets. People still brush their teeth, wash dishes, buy soap, and feed pets. The company also sells in many countries, so one weak market does not decide the whole story.

The better news in Q1 2026 was that growth was more volume-led. Management said organic sales growth accelerated from Q4, helped by improved volume in Asia Pacific. The internal view also points to Latin America as part of that recovery. That matters because it suggests prior price increases did not fully break demand.

The problem is the cost line. Management disclosed an added raw materials and logistics headwind of roughly $300 million for the year. That shifts the bear case back to margin pressure, even after Q1 revenue rose to $5.324 billion from $4.911 billion and gross margin was 60.6%.

Finn's view is balanced. Colgate has strong brands and Hill's remains a good growth engine. But North America is still weak, the skin health business took a large Filorga-related impairment in 2025, and the new productivity savings are mostly expected in 2027 and 2028 rather than right away.

May 2026▼Q1 2026 showed a better volume-led sales rebound, helped by Asia Pacific and Latin America. The view still moved more cautious because management added roughly $300 million of raw materials and logistics pressure for the year.

Feb 2026▼The 2025 10-K showed organic sales growth slowed to 1.4%, and non-GAAP gross margin contracted by 50 basis points. The company also recorded a $919 million pre-tax impairment tied to skin health, mainly Filorga.

Oct 2025→The Q3 2025 filing did not add meaningful new business detail and said risk factors had not materially changed. The thesis stayed focused on stable brands versus competition, currency, and cost pressure.

Aug 2025→The Q2 2025 filing was brief and did not include new Management's Discussion and Analysis. No material risk factor change was reported.

Apr 2025→The Q1 2025 filing did not provide enough accessible operating detail to change the view. The company reported no material risk factor changes from the prior annual report.

Feb 2025→The initial thesis was built from the 2024 10-K. Colgate was framed as a defensive global brand company with two main segments, but with real currency, retail, and competitive risks.

Oct 2024→The Q3 2024 filing lacked standard Management's Discussion and Analysis and did not change the thesis. A CEO 10b5-1 trading plan was disclosed and treated as routine.

02 Business model

Small items, huge reach

Colgate makes money by selling branded consumer products through retailers, wholesalers, distributors, dental professionals, veterinarians, eCommerce, and some direct channels. Walmart was 11% of 2024 sales, so large retailers have real bargaining power.

The core engine is Oral, Personal and Home Care. Oral Care alone was 44% of 2025 net sales. This category is useful because toothpaste and toothbrushes are repeat purchases, and Colgate has leading global brands.

Hill's Pet Nutrition is the second engine. It sells Science Diet for general wellness and Prescription Diet for medical pet needs. Prescription Diet also gives the company a link to veterinarians, which can make the business less like a normal grocery aisle product.

The model can break when costs jump faster than prices. Oil-linked resins, packaging, and logistics can squeeze gross margin. Colgate's answer is pricing, revenue growth management, and its Strategic Growth and Productivity Program, but those moves can hurt volume if shoppers push back.

03 Product portfolio

Toothpaste first, pets second

Cash cow

Oral Care

This includes Colgate, elmex, meridol, and Tom's of Maine. Oral Care was 44% of 2025 net sales and is the center of the company.

Growth engine

Hill's Pet Nutrition

Hill's Science Diet and Hill's Prescription Diet made up 23% of 2025 net sales. The business is still viewed as a durable growth engine, even after exiting some private label work.

Steady

Personal Care

This includes Palmolive, Softsoap, Irish Spring, EltaMD, and Filorga. Personal Care was 17% of 2025 net sales, but skin health is now a watch item after the 2025 impairment.

Steady

Home Care

This includes Palmolive dish liquids, Fabuloso, and Ajax. Home Care was 16% of 2025 net sales and adds scale in household repeat purchases.

Option

Skin health

EltaMD and Filorga were meant to add higher-growth personal care exposure. Filorga is now an open question after a $919 million pre-tax impairment tied mainly to weaker performance in China.

04 Business segments

Two reporting segments

Oral, Personal and Home Care77%modest

Hill's Pet Nutrition23%modest

The segment mix uses fiscal 2025 net sales: Oral, Personal and Home Care was about $15.8 billion, and Hill's Pet Nutrition was about $4.6 billion. About two-thirds of total sales come from outside the U.S., and Walmart was 11% of 2024 sales.

05 Risk factors

What could go wrong

Cost inflation eats the margin

High impact · Medium odds

Management called out roughly $300 million of added raw materials and logistics pressure for 2026. Oil-linked resins, packaging, and freight can move fast. If costs keep rising, Colgate may have to choose between lower margins and price increases that slow volume.

We watchGross margin, oil-linked resin costs, freight costs, and any update to the $300 million headwind.

North America stays weak

Medium impact · Medium odds

North America is still lagging while competitors use more coupons and promotions. Management said the region needs a strategy reset. If the reset fails, the company may keep losing volume or spend more to defend share.

We watchNorth America volume and mix, couponing levels, and management comments on the strategy reset.

Price hikes hurt the volume rebound

High impact · Medium odds

The bull case needs volume growth to continue in Asia Pacific and Latin America. More pricing may be needed to offset the new cost headwind. The risk is that shoppers trade down, buy less, or switch to local brands.

We watchOrganic volume growth in Asia Pacific and Latin America after new pricing or revenue growth management actions.

Retailers gain more power

Medium impact · High odds

Colgate sells through large retailers, wholesalers, and online channels. Walmart alone was 11% of 2024 sales. Big retailers can push for lower prices, more trade spending, or different shelf space.

We watchTrade spending, Walmart concentration, eCommerce pricing, and signs of shelf share loss.

Skin health capital allocation disappoints

Medium impact · Medium odds

In 2025, Colgate recorded a $919 million pre-tax impairment tied to the skin health business, mainly Filorga. That raises questions about past deal discipline and the future plan for the category. A weak reset could keep dragging on Personal Care growth.

We watchManagement's long-term plan for Filorga and EltaMD, China performance, and any further impairment charges.

Global exposure cuts both ways

Medium impact · Medium odds

Roughly two-thirds of sales come from outside the U.S., and emerging markets are about 45% of net sales. That gives Colgate growth chances, but also adds currency, trade, and political risk. A strong U.S. dollar can reduce reported sales and profit.

We watchForeign exchange impact on net sales, emerging market volume, and changes in trade policy.

06 Quick answers

In one breath

What does Colgate-Palmolive actually sell?

It sells toothpaste, toothbrushes, soaps, dish liquids, cleaners, skin care, and Hill's pet food. Oral Care is the biggest product group, at 44% of 2025 net sales.

Why is Hill's Pet Nutrition important to Colgate?

Hill's gives Colgate a pet health business with premium and veterinary-linked products. It was 23% of 2025 net sales and remains one of the clearer growth engines.

What changed in Q1 2026?

Revenue growth improved, helped by better volume in Asia Pacific and Latin America. The offset was a new roughly $300 million raw materials and logistics headwind that lowered the margin outlook.

What is the biggest risk for Colgate right now?

The biggest near-term risk is margin pressure. If costs rise and shoppers reject more price increases, Colgate could lose some of the volume momentum that returned in Q1 2026.